The purpose of this study is to find out if giving reolysin in combination with FOLFOX6/ bevacizumab can offer better results than standard therapy with FOLFOX6/ bevacizumab.
Study Type: Interventional (Clinical Trial)
Actual Enrollment: 109 participants
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Phase II Study of Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Patients With Metastatic Colorectal Cancer.
Actual Study Start Date: June 11, 2012
Actual Primary Completion Date: January 18, 2017
Actual Study Completion Date: September 12, 2018
- Active Comparator: Folfox plus Bevacizumab and Reolysin
- Active Comparator: Folfox plus Bevacizumab
|Date last updated at source||2012-06-12|
|Study start date||2012-06-11|
|Estimated primary completion date||2017-12-01|